Overview

Bioequivalency Study of Perindopril Erbumine 8 mg Tablet Under Fed Conditions

Status:
Completed
Trial end date:
2007-05-01
Target enrollment:
Participant gender:
Summary
The objective of this study was to prove the bioequivalence of Perindopril Erbumine 8 mg tablet under fed conditions
Phase:
N/A
Details
Lead Sponsor:
Roxane Laboratories
Treatments:
Perindopril